Pages that link to "Q33852649"
Jump to navigation
Jump to search
The following pages link to Signaling by ABL oncogenes through cyclin D1. (Q33852649):
Displaying 33 items.
- Protein binding and signaling properties of RIN1 suggest a unique effector function (Q24319548) (← links)
- Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. (Q30176527) (← links)
- Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells (Q31055456) (← links)
- The role of STATs in myeloid differentiation and leukemia (Q33941366) (← links)
- Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained (Q34047859) (← links)
- Bcr-Abl variants: biological and clinical aspects (Q34145565) (← links)
- Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA (Q34167898) (← links)
- Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory (Q34235845) (← links)
- Molecular biology of chronic myeloid leukemia (Q34246740) (← links)
- Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. (Q34250223) (← links)
- NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression (Q34283905) (← links)
- Modeling Philadelphia chromosome positive leukemias (Q34405446) (← links)
- Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations (Q37591815) (← links)
- Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia (Q37738464) (← links)
- DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia (Q38941081) (← links)
- Gastric cancer cell lines AGS before and after CD40 signal activating. (Q39393465) (← links)
- Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase. (Q40024199) (← links)
- Bcr‐Abl upregulates cytosolic p21WAF‐1/CIP‐1 by a phosphoinositide‐3‐kinase (PI3K)‐independent pathway (Q40631425) (← links)
- BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway (Q40852113) (← links)
- Regulation of cell cycle entry and G1 progression by CSF-1. (Q41289882) (← links)
- Signal transduction by wild-type and leukemogenic Abl proteins. (Q41679375) (← links)
- Stem cells in chronic myelogenous leukemia (Q41689634) (← links)
- Molecular Genetics of Childhood Leukemias (Q41712509) (← links)
- Biology of chronic myelogenous leukemia (Q41729929) (← links)
- Key Effectors of Signal Transduction and G 1 Progression (Q41750240) (← links)
- Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma. (Q41890375) (← links)
- Do cells need CDK2 and ... Bcr-Abl? (Q44699399) (← links)
- Haemopoietic transformation by the TEL/ABL oncogene. (Q47720679) (← links)
- Regulation of the Cell Cycle by the Rb Tumor Suppressor Family (Q47818764) (← links)
- Chronic myelogenous leukemia molecular signature. (Q47821781) (← links)
- Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation (Q62819858) (← links)
- Flow cytometric analysis of aneuploidy and S-phase fraction in chronic myeloid leukemia patients: role in early detection of accelerated phase (Q73668254) (← links)
- BCR/ABL, mRNA translation and apoptosis (Q81677017) (← links)